Comprehensive Financial Consultants Institutional’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Buy |
30,455
+3,523
| +13% | +$276K | 0.78% | 45 |
|
|
2025
Q1 | $1.95M | Buy |
26,932
+2,304
| +9% | +$167K | 0.69% | 51 |
|
|
2024
Q4 | $1.82M | Buy |
24,628
+1,971
| +9% | +$146K | 0.66% | 53 |
|
|
2024
Q3 | $1.5M | Buy |
22,657
+824
| +4% | +$54.4K | 0.55% | 70 |
|
|
2024
Q2 | $2.02M | Buy |
21,833
+1,397
| +7% | +$129K | 0.79% | 45 |
|
|
2024
Q1 | $1.95M | Buy |
20,436
+1,619
| +9% | +$155K | 0.81% | 47 |
|
|
2023
Q4 | $1.43M | Buy |
18,817
+2,555
| +16% | +$195K | 0.67% | 63 |
|
|
2023
Q3 | $1.13M | Buy |
16,262
+2,534
| +18% | +$176K | 0.59% | 67 |
|
|
2023
Q2 | $1.27M | Buy |
13,728
+935
| +7% | +$86.6K | 0.67% | 60 |
|
|
2023
Q1 | $1.06M | Buy |
12,793
+1,000
| +8% | +$82.7K | 0.6% | 65 |
|
|
2022
Q4 | $917K | Buy |
11,793
+1,010
| +9% | +$78.5K | 0.55% | 69 |
|
|
2022
Q3 | $921K | Buy |
10,783
+419
| +4% | +$35.8K | 0.61% | 58 |
|
|
2022
Q2 | $998K | Buy |
10,364
+104
| +1% | +$10K | 0.71% | 50 |
|
|
2022
Q1 | $1.03M | Buy |
10,260
+797
| +8% | +$80.1K | 0.72% | 46 |
|
|
2021
Q4 | $1.07M | Buy |
+9,463
| New | +$1.07M | 0.69% | 44 |
|